Spruce Biosciences (SPRB) News Today → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free SPRB Stock Alerts $0.68 +0.00 (+0.45%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 2:16 AM | americanbankingnews.comSpruce Biosciences, Inc. to Post Q1 2025 Earnings of ($0.29) Per Share, HC Wainwright Forecasts (NASDAQ:SPRB)June 9 at 3:36 AM | americanbankingnews.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Recommendation of "Hold" from AnalystsJune 5, 2024 | americanbankingnews.comSpruce Biosciences (NASDAQ:SPRB) Receives Neutral Rating from HC WainwrightJune 4, 2024 | businesswire.comSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)June 3, 2024 | businesswire.comSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024May 23, 2024 | finance.yahoo.comSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceMay 23, 2024 | businesswire.comSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceMay 16, 2024 | markets.businessinsider.comHold Rating on Spruce Biosciences Amid Clinical Trial Uncertainties and Rising CompetitionMay 16, 2024 | finance.yahoo.comSpruce Biosciences, Inc. (SPRB)May 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Spruce Biosciences Amid Upcoming Trial Data and Strong Financial PositionMay 13, 2024 | msn.comSPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024May 13, 2024 | businesswire.comSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesApril 30, 2024 | finance.yahoo.comSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingApril 26, 2024 | investing.comSpruce Biosciences Inc (SPRB)April 22, 2024 | businesswire.comSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBMarch 23, 2024 | finance.yahoo.comRevenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)March 22, 2024 | insidertrades.comHoldings A/S Novo Sells 359,979 Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) StockMarch 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBMarch 19, 2024 | insidertrades.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Major Shareholder Holdings A/S Novo Sells 1,912,316 SharesMarch 16, 2024 | finance.yahoo.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Just Reported Earnings, And Analysts Cut Their Target PriceMarch 15, 2024 | marketbeat.comSpruce Biosciences (NASDAQ:SPRB) Stock Rating Lowered by Leerink PartnrsLeerink Partnrs lowered shares of Spruce Biosciences from an "outperform" rating to a "market perform" rating in a report on Thursday.March 14, 2024 | marketwatch.comSpruce Biosciences Shares Dive 74% After Terminating Genetic Disease Study, Cutting StaffMarch 14, 2024 | markets.businessinsider.comSpruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock FreefallMarch 14, 2024 | businesswire.comSpruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsMarch 14, 2024 | marketwatch.comStocks to Watch: Spruce Biosciences, UiPathMarch 14, 2024 | markets.businessinsider.comSpruce Biosciences FY23 Loss Widens, CAHmelia-203 Study Fails; Stock Down In Pre-marketMarch 14, 2024 | msn.comWhy Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?March 14, 2024 | marketbeat.comSpruce Biosciences (NASDAQ:SPRB) Downgraded by GuggenheimGuggenheim cut Spruce Biosciences from a "buy" rating to a "neutral" rating in a research report on Thursday.March 14, 2024 | investorplace.comWhy Is Spruce Biosciences (SPRB) Stock Down 78% Today?March 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Spruce Biosciences Amid Clinical Trial Optimism and Advancing Dose CohortsMarch 13, 2024 | msn.comSpruce Biosciences stock craters 75% on failed Phase 2 studyMarch 13, 2024 | finance.yahoo.comSpruce Biosciences Inc (SPRB) Reports Full Year 2023 Financial Results Amid Clinical Trial SetbacksMarch 13, 2024 | marketbeat.comTrading was temporarily halted for "SPRB" at 04:03 PM with a stated reason of "News pending."March 13, 2024 | businesswire.comSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesMarch 13, 2024 | businesswire.comSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHMarch 13, 2024 | marketbeat.comSpruce Biosciences (SPRB) to Release Earnings on ThursdaySpruce Biosciences (NASDAQ:SPRB) will be releasing earnings on Thursday, March 14, Yahoo Finance reports.March 5, 2024 | marketbeat.comSpruce Biosciences' (SPRB) Outperform Rating Reiterated at Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and issued a $9.00 target price on shares of Spruce Biosciences in a research report on Tuesday.March 3, 2024 | marketbeat.comArmistice Capital LLC Cuts Stake in Spruce Biosciences, Inc. (NASDAQ:SPRB)Armistice Capital LLC trimmed its position in Spruce Biosciences, Inc. (NASDAQ:SPRB - Free Report) by 12.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,056,000 shares of the company's stock after selling 442,000 shares during the pFebruary 26, 2024 | marketbeat.comSpruce Biosciences (NASDAQ:SPRB) PT Raised to $9.00 at Royal Bank of CanadaRoyal Bank of Canada boosted their target price on Spruce Biosciences from $8.00 to $9.00 and gave the company an "outperform" rating in a research report on Monday.February 23, 2024 | benzinga.comSpruce Biosciences Stock (NASDAQ:SPRB), Short Interest ReportFebruary 21, 2024 | msn.comGuggenheim starts Spruce Biosciences at buy, cites near-term catalystsFebruary 21, 2024 | msn.comGuggenheim Initiates Coverage of Spruce Biosciences (SPRB) with Buy RecommendationFebruary 16, 2024 | marketbeat.comAIGH Capital Management LLC Has $2.74 Million Holdings in Spruce Biosciences, Inc. (NASDAQ:SPRB)AIGH Capital Management LLC grew its stake in shares of Spruce Biosciences, Inc. (NASDAQ:SPRB - Free Report) by 9.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,211,000 shares of the company's stock after buying an additional 100,0February 5, 2024 | marketbeat.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Recommendation of "Buy" from AnalystsSpruce Biosciences, Inc. (NASDAQ:SPRB - Get Free Report) has received an average rating of "Buy" from the six brokerages that are presently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month target pricJanuary 30, 2024 | finance.yahoo.comSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceJanuary 25, 2024 | marketbeat.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Down 74.4% in JanuarySpruce Biosciences, Inc. (NASDAQ:SPRB - Get Free Report) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 19,700 shares, a decrease of 74.4% from the December 31st total of 77,000 shares. Based on an average daily trading volume, of 180,400 shares, the short-interest ratio is presently 0.1 days.January 22, 2024 | finance.yahoo.comSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaJanuary 12, 2024 | marketbeat.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Sees Significant Increase in Short InterestSpruce Biosciences, Inc. (NASDAQ:SPRB - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 77,000 shares, an increase of 64.5% from the December 15th total of 46,800 shares. Based on an average trading volume of 176,000 shares, the days-to-cover ratio is presently 0.4 days. Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRB and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. SPRB Media Mentions By Week SPRB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRB News Sentiment▼0.000.76▲Average Medical News Sentiment SPRB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRB Articles This Week▼51▲SPRB Articles Average Week Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eagle Pharmaceuticals News Today Adicet Bio News Today Immunic News Today Coya Therapeutics News Today DiaMedica Therapeutics News Today Vistagen Therapeutics News Today PDS Biotechnology News Today Cellectar Biosciences News Today Tiziana Life Sciences News Today Allakos News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPRB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored